miR-886-3p is reported to modulate the proliferation of SCLC cells using Polo-like kinase 1 (PLK1) and transforming growth factor-beta 1 (TGF-β1) in vitro [33]. The gene discussed is PLK1; the disease is small cell lung carcinoma.